Triazolam and nitrazepam use in elderly outpatients

Area of Science:

• Geriatric pharmacology
• Sleep medicine
• Clinical drug trials

Background:

• Benzodiazepines are commonly prescribed for sleep disturbances in the elderly.
• Triazolam and nitrazepam are frequently used hypnotics with differing pharmacokinetic profiles.
• Understanding their comparative effects on sleep and adverse reactions is crucial for optimizing patient care.

Purpose of the Study:

• To compare the adverse reactions and sleep effects of triazolam and nitrazepam in elderly outpatients.
• To evaluate the impact of these benzodiazepines on sleep maintenance and sleep onset latency.
• To identify potential differences in nocturia-related awakenings and subsequent sleep recovery.

Main Methods:

• A comparative study involving three groups: triazolam users, nitrazepam users, and a control group.
• Data collection via telephone interviews with study participants.
• Inclusion criteria: outpatients aged over 60 years.

Main Results:

• No significant difference in mid-sleep awakening rates between triazolam (61.7%) and nitrazepam (69.4%) groups.
• Nocturia incidence, a primary cause of awakening, was similar between triazolam (36.2%) and nitrazepam (41.7%) groups.
• Significantly lower difficulty returning to sleep was reported in the nitrazepam group (8%) compared to triazolam (62.1%) and control (11.1%) groups (p < 0.01).

Conclusions:

• Nitrazepam demonstrates a significant advantage over triazolam in facilitating sleep return after awakenings.
• Elderly patients with nocturia-induced sleep disruptions may benefit more from nitrazepam.
• These findings suggest a potential role for nitrazepam in managing sleep disturbances in geriatric populations with specific needs.